APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 213 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $15,782,893 | +77.1% | 173,248 | +28.2% | 0.62% | +82.3% |
| Q1 2023 | $8,912,779 | +159.5% | 135,124 | +103.4% | 0.34% | +160.8% |
| Q4 2022 | $3,434,888 | -81.1% | 66,426 | -75.0% | 0.13% | -82.5% |
| Q3 2022 | $18,173,000 | +28.7% | 266,076 | -14.8% | 0.74% | +34.1% |
| Q2 2022 | $14,117,000 | +41.9% | 312,192 | +59.4% | 0.56% | +59.0% |
| Q1 2022 | $9,950,000 | +7.5% | 195,820 | 0.0% | 0.35% | +17.1% |
| Q4 2021 | $9,258,000 | +43.4% | 195,820 | 0.0% | 0.30% | +43.3% |
| Q3 2021 | $6,454,000 | -33.0% | 195,820 | +28.4% | 0.21% | -33.5% |
| Q2 2021 | $9,640,000 | +47.3% | 152,538 | 0.0% | 0.31% | +39.1% |
| Q1 2021 | $6,545,000 | -47.0% | 152,538 | -29.4% | 0.22% | -48.2% |
| Q4 2020 | $12,356,000 | +89.6% | 216,017 | 0.0% | 0.43% | +77.9% |
| Q3 2020 | $6,517,000 | +15.0% | 216,017 | +24.5% | 0.24% | +13.0% |
| Q2 2020 | $5,666,000 | +21.9% | 173,494 | 0.0% | 0.22% | +2.9% |
| Q1 2020 | $4,648,000 | +15.9% | 173,494 | +32.4% | 0.21% | +38.2% |
| Q4 2019 | $4,011,000 | +68.5% | 130,999 | +32.6% | 0.15% | +46.2% |
| Q3 2019 | $2,380,000 | – | 98,784 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |